752 related articles for article (PubMed ID: 25905624)
21. Transformation of acidic poorly water soluble drugs into ionic liquids.
Balk A; Wiest J; Widmer T; Galli B; Holzgrabe U; Meinel L
Eur J Pharm Biopharm; 2015 Aug; 94():73-82. PubMed ID: 25976317
[TBL] [Abstract][Full Text] [Related]
22. A new self-emulsifying formulation of itraconazole with improved dissolution and oral absorption.
Hong JY; Kim JK; Song YK; Park JS; Kim CK
J Control Release; 2006 Jan; 110(2):332-338. PubMed ID: 16297483
[TBL] [Abstract][Full Text] [Related]
23. Polyvinylidene fluoride-Hyaluronic acid wound dressing comprised of ionic liquids for controlled drug delivery and dual therapeutic behavior.
Abednejad A; Ghaee A; Morais ES; Sharma M; Neves BM; Freire MG; Nourmohammadi J; Mehrizi AA
Acta Biomater; 2019 Dec; 100():142-157. PubMed ID: 31586728
[TBL] [Abstract][Full Text] [Related]
24. In situ intestinal permeability and in vivo oral bioavailability of celecoxib in supersaturating self-emulsifying drug delivery system.
Song WH; Yeom DW; Lee DH; Lee KM; Yoo HJ; Chae BR; Song SH; Choi YW
Arch Pharm Res; 2014 May; 37(5):626-35. PubMed ID: 23852645
[TBL] [Abstract][Full Text] [Related]
25. Solubilisation behaviour of poorly water-soluble drugs during digestion of solid SMEDDS.
Vithani K; Hawley A; Jannin V; Pouton C; Boyd BJ
Eur J Pharm Biopharm; 2018 Sep; 130():236-246. PubMed ID: 29981444
[TBL] [Abstract][Full Text] [Related]
26. 'Pro et contra' ionic liquid drugs - Challenges and opportunities for pharmaceutical translation.
Balk A; Holzgrabe U; Meinel L
Eur J Pharm Biopharm; 2015 Aug; 94():291-304. PubMed ID: 26070389
[TBL] [Abstract][Full Text] [Related]
27. PEGylated bile acids for use in drug delivery systems: enhanced solubility and bioavailability of itraconazole.
Le Dévédec F; Strandman S; Hildgen P; Leclair G; Zhu XX
Mol Pharm; 2013 Aug; 10(8):3057-66. PubMed ID: 23837910
[TBL] [Abstract][Full Text] [Related]
28. Pluronic-Functionalized Silica-Lipid Hybrid Microparticles: Improving the Oral Delivery of Poorly Water-Soluble Weak Bases.
Rao S; Richter K; Nguyen TH; Boyd BJ; Porter CJ; Tan A; Prestidge CA
Mol Pharm; 2015 Dec; 12(12):4424-33. PubMed ID: 26523928
[TBL] [Abstract][Full Text] [Related]
29. Digestion is a critical element for absorption of cinnarizine from supersaturated lipid-based type I formulations.
Paulus F; Bauer-Brandl A; Stappaerts J; Holm R
Eur J Pharm Sci; 2024 Jan; 192():106634. PubMed ID: 37951315
[TBL] [Abstract][Full Text] [Related]
30. Gastric pre-processing is an important determinant of the ability of medium-chain lipid solution formulations to enhance oral bioavailability in rats.
Lee KW; Porter CJ; Boyd BJ
J Pharm Sci; 2013 Nov; 102(11):3957-65. PubMed ID: 23983139
[TBL] [Abstract][Full Text] [Related]
31. Solution or suspension - Does it matter for lipid based systems? In vivo studies of chase dosing lipid vehicles with aqueous suspensions of a poorly soluble drug.
Larsen AT; Holm R; Müllertz A
Eur J Pharm Biopharm; 2017 Aug; 117():308-314. PubMed ID: 28465239
[TBL] [Abstract][Full Text] [Related]
32. Self-emulsifying drug delivery systems (SEDDS) disrupt the gut microbiota and trigger an intestinal inflammatory response in rats.
Subramaniam S; Elz A; Wignall A; Kamath S; Ariaee A; Hunter A; Newblack T; Wardill HR; Prestidge CA; Joyce P
Int J Pharm; 2023 Dec; 648():123614. PubMed ID: 37979632
[TBL] [Abstract][Full Text] [Related]
33. Lipophilic Salts and Lipid-Based Formulations for Bridging the Food Effect Gap of Venetoclax.
Koehl NJ; Henze LJ; Holm R; Kuentz M; Keating JJ; De Vijlder T; Marx A; Griffin BT
J Pharm Sci; 2022 Jan; 111(1):164-174. PubMed ID: 34516990
[TBL] [Abstract][Full Text] [Related]
34. Choline- versus imidazole-based ionic liquids as functional ingredients in topical delivery systems: cytotoxicity, solubility, and skin permeation studies.
Santos de Almeida T; Júlio A; Saraiva N; Fernandes AS; Araújo MEM; Baby AR; Rosado C; Mota JP
Drug Dev Ind Pharm; 2017 Nov; 43(11):1858-1865. PubMed ID: 28665154
[TBL] [Abstract][Full Text] [Related]
35. Biocompatible Cationic Lipoamino Acids as Counterions for Oral Administration of API-Ionic Liquids.
Lai A; Leong N; Zheng D; Ford L; Nguyen TH; Williams HD; Benameur H; Scammells PJ; Porter CJH
Pharm Res; 2022 Oct; 39(10):2405-2419. PubMed ID: 35661084
[TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo evaluations of the performance of an indirubin derivative, formulated in four different self-emulsifying drug delivery systems.
Heshmati N; Cheng X; Dapat E; Sassene P; Eisenbrand G; Fricker G; Müllertz A
J Pharm Pharmacol; 2014 Nov; 66(11):1567-75. PubMed ID: 24961657
[TBL] [Abstract][Full Text] [Related]
37. Examination of the impact of a range of Pluronic surfactants on the in-vitro solubilisation behaviour and oral bioavailability of lipidic formulations of atovaquone.
Sek L; Boyd BJ; Charman WN; Porter CJ
J Pharm Pharmacol; 2006 Jun; 58(6):809-20. PubMed ID: 16734982
[TBL] [Abstract][Full Text] [Related]
38. Ionic liquids in drug delivery.
Shamshina JL; Barber PS; Rogers RD
Expert Opin Drug Deliv; 2013 Oct; 10(10):1367-81. PubMed ID: 23795613
[TBL] [Abstract][Full Text] [Related]
39. Ionic liquids as ingredients in topical drug delivery systems.
Dobler D; Schmidts T; Klingenhöfer I; Runkel F
Int J Pharm; 2013 Jan; 441(1-2):620-7. PubMed ID: 23123180
[TBL] [Abstract][Full Text] [Related]
40. Enabling superior drug loading in lipid-based formulations with lipophilic salts for a brick dust molecule: Exploration of lipophilic counterions and in vitro-in vivo evaluation.
Sirvi A; Jadhav K; Sangamwar AT
Int J Pharm; 2024 May; 656():124108. PubMed ID: 38604540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
